
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [ALNY] Alnylam Pharmaceuticals Inc
Data updated 2025-Jul-11 (Friday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-Jul-11 Friday
Open | $321.12 | High | $321.12 0.00% |
---|---|---|---|
Close | $314.94 | Low | $312.96 -2.54% |
Volume | 1.08 Million 0.93x | Volatility | 2.61% |
Change |
$-7.70
-2.39%
|
Streak | ↓ 1 days -2.39% |
20d SMA | $318.16 -1.0% | 50d SMA | $298.02 +5.7% | 100d SMA | $273.28 +15.2% | 200d SMA | $268.16 +17.4% |
RSI | 52 | MACD | -1.95 | ADX | 28.0 | Stochastic Oscillator | 44.8 50.9 |
CCI | -9.0 | ATR | 9.44 | OBV | 110 Million | Chaikin A/D | 83 Million |
Market Cap | 42.3 B | PEG Ratio | -0.49 | Trailing P/E | Forward P/E | 2 K | |
Price/Sales (ttm) | 18 | Price/Book (mrq) | 362 | EV/Revenue (ttm) | 17.3 | EV/EBITDA (ttm) | 205 |
% Held by Insiders | 3.80% | % Held by Institutions | 97.50% | Shares Short | 2.69 M | Shares Short (prior month) | 3.99 M |
Short Ratio | 2.1 | Short % of Outstanding | 2.06% | Short % of Float | 2.14% | Shares Short Change (mom) | -32.6% |
Revenue/Share (ttm) | $18.27 | Profit Margin (ttm) | -11.50% | Operating Margin (ttm) | 3.04% | EBITDA (ttm) | -57.8 M |
Diluted EPS (ttm) | $-2.09 | Current Ratio (mrq) | 3.08 | Return on Assets (ttm) | -1.79% | Return on Equity (ttm) | -1,501.00% |
Qtr Earnings Growth (yoy) | 0.00% | Qtr Revenue Growth (yoy) | 20.20% | Operating Cash Flow (ttm) | 104 M | Free Cash Flow (ttm) | 147 M |
Choose view type
Daily Performance for Alnylam Pharmaceuticals Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Alnylam Pharmaceuticals Inc up to close of 2025-Jul-11 at $314.94
1-month Performance Benchmarks for Alnylam Pharmaceuticals Inc:
Related to Alnylam Pharmaceuticals Inc
Information for Alnylam Pharmaceuticals Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jul-11 on Google
SEC Reports : Quarterly reports around 2025-Jul-11 on SEC Edgar
Compare Alnylam Pharmaceuticals Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Alnylam Pharmaceuticals Inc
Industry : Biotechnology industry performance which includes Alnylam Pharmaceuticals Inc